Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
2001 1
2002 5
2003 9
2004 6
2005 8
2006 8
2007 11
2008 10
2009 8
2010 7
2011 13
2012 8
2013 10
2014 2
2015 6
2016 1
2017 8
2018 11
2019 7
2020 7
2021 11
2022 6
2023 4
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

152 results

Results by year

Filters applied: . Clear all
Page 1
RLIP76 and Cancer.
Awasthi S, Singhal SS, Awasthi YC, Martin B, Woo JH, Cunningham CC, Frankel AE. Awasthi S, et al. Clin Cancer Res. 2008 Jul 15;14(14):4372-7. doi: 10.1158/1078-0432.CCR-08-0145. Clin Cancer Res. 2008. PMID: 18628450 Free PMC article. Review.
Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study.
Tabernero J, Yoshino T, Cohn AL, Obermannova R, Bodoky G, Garcia-Carbonero R, Ciuleanu TE, Portnoy DC, Van Cutsem E, Grothey A, Prausová J, Garcia-Alfonso P, Yamazaki K, Clingan PR, Lonardi S, Kim TW, Simms L, Chang SC, Nasroulah F; RAISE Study Investigators. Tabernero J, et al. Lancet Oncol. 2015 May;16(5):499-508. doi: 10.1016/S1470-2045(15)70127-0. Epub 2015 Apr 12. Lancet Oncol. 2015. PMID: 25877855 Clinical Trial.
Therapeutic targeting of miRNA-216b in cancer.
Jana S, Krishna M, Singhal J, Horne D, Awasthi S, Salgia R, Singhal SS. Jana S, et al. Among authors: awasthi s. Cancer Lett. 2020 Aug 1;484:16-28. doi: 10.1016/j.canlet.2020.04.020. Epub 2020 May 5. Cancer Lett. 2020. PMID: 32387443 Review.
Activating p53 function by targeting RLIP.
Singhal SS, Horne D, Singhal J, Awasthi S, Salgia R. Singhal SS, et al. Among authors: awasthi s. Biochim Biophys Acta Rev Cancer. 2021 Apr;1875(2):188512. doi: 10.1016/j.bbcan.2021.188512. Epub 2021 Jan 15. Biochim Biophys Acta Rev Cancer. 2021. PMID: 33460725 Free PMC article. Review.
RLIP: An existential requirement for breast carcinogenesis.
Singhal SS, Salgia R, Singhal S, Horne D, Awasthi S. Singhal SS, et al. Among authors: awasthi s. Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):281-288. doi: 10.1016/j.bbcan.2019.02.001. Epub 2019 Feb 13. Biochim Biophys Acta Rev Cancer. 2019. PMID: 30771458 Review.
Editorial.
Awasthi S. Awasthi S. Biologics. 2007 Mar;1(1):1-2. Biologics. 2007. PMID: 19707342 Free PMC article. No abstract available.
RLIP76 Targeted Therapy for Kidney Cancer.
Singhal SS, Singhal J, Figarola J, Horne D, Awasthi S. Singhal SS, et al. Among authors: awasthi s. Pharm Res. 2015 Oct;32(10):3123-36. doi: 10.1007/s11095-015-1723-1. Epub 2015 May 29. Pharm Res. 2015. PMID: 26021465 Free PMC article. Review.
152 results